1. Home
  2. CLDX vs CHRN Comparison

CLDX vs CHRN Comparison

Compare CLDX & CHRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Celldex Therapeutics Inc.

CLDX

Celldex Therapeutics Inc.

SELL

Current Price

$28.36

Market Cap

3.0B

Sector

Health Care

ML Signal

SELL

Logo ChronoScale Corporation Common Stock

CHRN

ChronoScale Corporation Common Stock

HOLD

Current Price

$10.37

Market Cap

2.9B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLDX
CHRN
Founded
N/A
2026
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.9B
IPO Year
1995
2012

Fundamental Metrics

Financial Performance
Metric
CLDX
CHRN
Price
$28.36
$10.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
2
Target Price
★ $63.07
$28.50
AVG Volume (30 Days)
★ 1.1M
144.2K
Earning Date
11-17-2026
11-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 92.67
EPS
N/A
★ N/A
Revenue
★ $12,743,000.00
N/A
Revenue This Year
$19.74
$84.77
Revenue Next Year
$373.52
$603.10
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 87.78
N/A
52 Week Low
$22.10
$11.41
52 Week High
$45.14
$30.00

Technical Indicators

Market Signals
Indicator
CLDX
CHRN
Relative Strength Index (RSI) 45.96 33.86
Support Level $28.34 N/A
Resistance Level $31.47 $22.29
Average True Range (ATR) 1.35 1.59
MACD 0.35 -0.24
Stochastic Oscillator 71.35 9.73

Price Performance

Historical Comparison
CLDX
CHRN

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About CHRN ChronoScale Corporation Common Stock

ChronoScale Holdings Corp is providing cloud services to customers at third-party colocation centers located in Colorado, Minnesota and Utah, such as artificial intelligence and machine learning developers, seeking to develop their products. It design, develop, and market exoskeleton and complementary products that augment human strength, endurance, and mobility. Its Cloud Business provides graphics processing unit (GPU) computing solutions that enable customers to execute critical workloads related to artificial intelligence (AI), machine learning (ML), rendering, and other High Performance Computing (HPC) tasks at scale in a capacity-constrained market. It has one operating segment Cloud Business.

Share on Social Networks: